Regulation of mTORC1 complex assembly and signaling by GRp58/ERp57

Molecular and Cellular Biology

Volumn 31, Issue 8, 2011, Pages 1657-1671

  Ramírez Rangel, Iliana ^a   Bracho Valdés, Ismael ^a   Vázquez Macías, Aleida ^a   Carretero Ortega, Jorge ^a   Reyes Cruz, Guadalupe ^a   Vázquez Prado, José ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOPLASMIC RETICULUM P57 PROTEIN; INITIATION FACTOR 4E BINDING PROTEIN 1; INSULIN; LEUCINE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MEMBRANE PROTEIN; PROTEIN DISULFIDE ISOMERASE; PROTEIN GRP58; PROTEIN RAPTOR; PROTEIN RICTOR; S6 KINASE; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CELL STRAIN HEK293; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSOL; ENDOPLASMIC RETICULUM; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MAMMAL CELL; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CELL PROLIFERATION; CYTOSOL; ENDOPLASMIC RETICULUM; HEK293 CELLS; HUMANS; PROTEIN BINDING; PROTEIN DISULFIDE-ISOMERASES; PROTEINS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

MAMMALIA; RAPTORES;

EID: 79953154067     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00824-10     Document Type: Article

References (55)

1. Adikesavan, A. K., E. Unni, and A. K. Jaiswal. 2008. Overlapping signal sequences control nuclear localization and endoplasmic reticulum retention of GRP58. Biochem. Biophys. Res. Commun. 377:407-412.
2. Beynon-Jones, S. M., A. N. Antoniou, and S. J. Powis. 2006. Mutational analysis of the oxidoreductase ERp57 reveals the importance of the two central residues in the redox motif. FEBS Lett. 580:1897-1902.
3. Chen, J. 2004. Novel regulatory mechanisms of mTOR signaling. Curr. Top. Microbiol. Immunol. 279:245-257.
4. Chichiarelli, S., et al. 2010. Role of ERp57 in the signaling and transcriptional activity of STAT3 in a melanoma cell line. Arch. Biochem. Biophys. 494:178-183.
5. Coe, H., J. Jung, J. Groenendyk, D. Prins, and M. Michalak. 2010. ERp57 modulates STAT3 signaling from the lumen of the endoplasmic reticulum. J. Biol. Chem. 285:6725-6738.
6. Coe, H., and M. Michalak. 2010. ERp57, a multifunctional endoplasmic reticulum resident oxidoreductase. Int. J. Biochem. Cell Biol. 42:796-799.
7. Dames, S. A., J. M. Mulet, K. Rathgeb-Szabo, M. N. Hall, and S. Grzesiek. 2005. The solution structure of the FATC domain of the protein kinase target of rapamycin suggests a role for redox-dependent structural and cellular stability. J. Biol. Chem. 280:20558-20564.
8. Dancey, J. E. 2006. Therapeutic targets: MTOR and related pathways. Cancer Biol. Ther. 5:1065-1073.
9. Drenan, R. M., X. Liu, P. G. Bertram, and X. F. Zheng. 2004. FKBP12-rapamycin-associated protein or mammalian target of rapamycin (FRAP/ mTOR) localization in the endoplasmic reticulum and the Golgi apparatus. J. Biol. Chem. 279:772-778.
10. Easton, J. B., and P. J. Houghton. 2006. mTOR and cancer therapy. Oncogene 25:6436-6446.
11. Facchinetti, V., et al. 2008. The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J. 27: 1932-1943.
12. Fasolo, A., and C. Sessa. 2008. mTOR inhibitors in the treatment of cancer. Expert Opin. Investig. Drugs 17:1717-1734.
13. Fingar, D. C., and J. Blenis. 2004. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23:3151-3171.
14. Fingar, D. C., S. Salama, C. Tsou, E. Harlow, and J. Blenis. 2002. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16:1472-1487.
15. Garbi, N., G. Hammerling, and S. Tanaka. 2007. Interaction of ERp57 and tapasin in the generation of MHC class I-peptide complexes. Curr. Opin. Immunol. 19:99-105.
16. Garbi, N., S. Tanaka, F. Momburg, and G. J. Hammerling. 2006. Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57. Nat. Immunol. 7:93-102.
17. Grillo, C., et al. 2006. Cooperative activity of Ref-1/APE and ERp57 in reductive activation of transcription factors. Free Radic. Biol. Med. 41:1113- 1123.
18. Guertin, D. A., et al. 2006. Ablation in mice of the mTORC components Raptor, Rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα, but not S6K1. Dev. Cell 11:859-871.
19. Guo, G. G., et al. 2002. Association of the chaperone glucose-regulated protein 58 (GRP58/ER-60/ERp57) with Stat3 in cytosol and plasma membrane complexes. J. Interferon Cytokine Res. 22:555-563.
20. Hanker, A. B., et al. 2010. Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling. Oncogene 29:380-391.
21. Hay, N., and N. Sonenberg. 2004. Upstream and downstream of mTOR. Genes Dev. 18:1926-1945.
22. Hernandez-Negrete, I., et al. 2007. P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration. J. Biol. Chem. 282: 23708-23715.
23. Ikenoue, T., K. Inoki, Q. Yang, X. Zhou, and K. L. Guan. 2008. Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 27:1919-1931.
24. Jacinto, E. 2008. What controls TOR? IUBMB Life 60:483-496.
25. Jacinto, E., et al. 2006. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127:125- 137.
26. Jiang, H., and P. K. Vogt. 2008. Constitutively active Rheb induces oncogenic transformation. Oncogene 27:5729-5740.
27. Kaizuka, T., et al. 2010. Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. J. Biol. Chem. 285:20109-20116.
28. Khanal, R. C., and I. Nemere. 2007. The ERp57/GRp58/1,25D3-MARRS receptor: multiple functional roles in diverse cell systems. Curr. Med. Chem. 14:1087-1093.
29. Kim, D. H., and D. M. Sabatini. 2004. Raptor and mTOR: subunits of a nutrient-sensitive complex. Curr. Top. Microbiol. Immunol. 279:259-270.
30. Kim, D. H., et al. 2002. mTOR interacts with raptor to form a nutrientsensitive complex that signals to the cell growth machinery. Cell 110:163- 175.
31. Kita, K., et al. 2006. Evidence for phosphorylation of rat liver glucoseregulated protein 58, GRP58/ERp57/ER-60, induced by fasting and leptin. FEBS Lett. 580:199-205.
32. Li, W., et al. 2007. Hypoxia-induced endothelial proliferation requires both mTORC1 and mTORC2. Circ. Res. 100:79-87.
33. Liu, X., and X. F. Zheng. 2007. Endoplasmic reticulum and Golgi localization sequences for mammalian target of rapamycin. Mol. Biol. Cell 18:1073- 1082.
34. Markus, M., and R. Benezra. 1999. Two isoforms of protein disulfide isomerase alter the dimerization status of E2A proteins by a redox mechanism. J. Biol. Chem. 274:1040-1049.
35. Ndubuisi, M. I., G. G. Guo, V. A. Fried, J. D. Etlinger, and P. B. Sehgal. 1999. Cellular physiology of STAT3: where's the cytoplasmic monomer? J. Biol. Chem. 274:25499-25509.
36. Neklesa, T. K., and R. W. Davis. 2008. Superoxide anions regulate TORC1 and its ability to bind Fpr1:rapamycin complex. Proc. Natl. Acad. Sci. U. S. A. 105:15166-15171.
37. Ni, M., and A. S. Lee. 2007. ER chaperones in mammalian development and human diseases. FEBS Lett. 581:3641-3651.
38. Polak, P., and M. N. Hall. 2006. mTORC2 Caught in a SINful Akt. Dev. Cell 11:433-434.
39. Qian, S. B., et al. 2010. mTORC1 links protein quality and quantity control by sensing chaperone availability. J. Biol. Chem. 285:27385-27395.
40. Rosner, M., and M. Hengstschlager. 2008. Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. Hum. Mol. Genet. 17:2934-2948.
41. Sancak, Y., et al. 2010. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141:290-303.
42. Sancak, Y., et al. 2008. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320:1496-1501.
43. Sarbassov, D. D., et al. 2004. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14:1296-1302.
44. Sarbassov, D. D., S. M. Ali, and D. M. Sabatini. 2005. Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17:596-603.
45. Sarbassov, D. D., et al. 2006. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22:159-168.
46. Sarbassov, D. D., D. A. Guertin, S. M. Ali, and D. M. Sabatini. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098-1101.
47. Sarbassov, D. D., and D. M. Sabatini. 2005. Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex. J. Biol. Chem. 280:39505- 39509.
48. Satoh, M., A. Shimada, A. Kashiwai, S. Saga, and M. Hosokawa. 2005. Differential cooperative enzymatic activities of protein disulfide isomerase family in protein folding. Cell Stress Chaperones 10:211-220.
49. Talvas, J., et al. 2008. Phospho-proteomic approach to identify new targets of leucine deprivation in muscle cells. Anal. Biochem. 381:148-150.
50. Toschi, A., et al. 2009. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Mol. Cell. Biol. 29:1411-1420.
51. Turano, C., S. Coppari, F. Altieri, and A. Ferraro. 2002. Proteins of the PDI family: unpredicted non-ER locations and functions. J. Cell Physiol. 193: 154-163.
52. Varma, S., and R. L. Khandelwal. 2007. Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB. Biochim. Biophys. Acta 1770:71-78.
53. Vazquez-Prado, J., J. Basile, and J. S. Gutkind. 2004. Modular architecture and novel protein-protein interactions regulating the RGS-containing Rho guanine nucleotide exchange factors. Methods Enzymol. 390:259-285.
54. Wang, X., and C. G. Proud. 2006. The mTOR pathway in the control of protein synthesis. Physiology (Bethesda) 21:362-369.
55. Wullschleger, S., R. Loewith, and M. N. Hall. 2006. TOR signaling in growth and metabolism. Cell 124:471-484.